Miller TP - Search Results

1

Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.

Garewal HS, Brooks RJ, Jones SE, Miller TP. Garewal HS, et al. Among authors: miller tp. J Clin Oncol. 1983 Dec;1(12):772-5. doi: 10.1200/JCO.1983.1.12.772. J Clin Oncol. 1983. PMID: 6422004

2

Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy.

Jones SE, Miller TP, Connors JM. Jones SE, et al. Among authors: miller tp. J Clin Oncol. 1989 Sep;7(9):1186-91. doi: 10.1200/JCO.1989.7.9.1186. J Clin Oncol. 1989. PMID: 2671279 Clinical Trial.

3

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.

Dixon DO, Neilan B, Jones SE, Lipschitz DA, Miller TP, Grozea PN, Wilson HE. Dixon DO, et al. Among authors: miller tp. J Clin Oncol. 1986 Mar;4(3):295-305. doi: 10.1200/JCO.1986.4.3.295. J Clin Oncol. 1986. PMID: 3512783 Clinical Trial.

4

Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma.

Braich TA, Salmon SE, Robertone A, Alberts DS, Jones SE, Miller TP, Garewal HS. Braich TA, et al. Among authors: miller tp. Invest New Drugs. 1986;4(3):269-74. doi: 10.1007/BF00179595. Invest New Drugs. 1986. PMID: 3818231

5

Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study.

Jones SE, Grozea PN, Miller TP, Van Slyck EJ, Balcerzak SP, Costanzi JJ, Morrison FS, Eyre HJ, Fabian CJ, Dabich L, et al. Jones SE, et al. Among authors: miller tp. J Clin Oncol. 1985 Oct;3(10):1318-24. doi: 10.1200/JCO.1985.3.10.1318. J Clin Oncol. 1985. PMID: 3900301 Clinical Trial.

6

Chemohormonal therapy for advanced breast cancer with tamoxifen, adriamycin, and cyclophosphamide (TAC).

Ahmann FR, Jones SE, Moon TE, Hammond N, Miller TP, Durie BG. Ahmann FR, et al. Among authors: miller tp. Cancer. 1985 Aug 15;56(4):730-7. doi: 10.1002/1097-0142(19850815)56:4<730::aid-cncr2820560405>3.0.co;2-e. Cancer. 1985. PMID: 4016669

7

Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors.

Miller TP, Jones SE, Chester A. Miller TP, et al. Cancer Treat Rep. 1980 Aug-Sep;64(8-9):1001-3. Cancer Treat Rep. 1980. PMID: 7448818

8

Initial chemotherapy for clinically localized lymphomas of unfavorable histology.

Miller TP, Jones SE. Miller TP, et al. Blood. 1983 Aug;62(2):413-8. Blood. 1983. PMID: 6688193 Free article.

9

Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase II Study.

Miller TP, Jones SE, Rainey JM. Miller TP, et al. Cancer Treat Rep. 1983 Jul-Aug;67(7-8):739-40. Cancer Treat Rep. 1983. PMID: 6688200 No abstract available.

10

Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.

Miller TP, Jones SE, Chester AB, Dorr RT. Miller TP, et al. Cancer Treat Rev. 1980 Sep;7 Suppl 1:81-6. doi: 10.1016/s0305-7372(80)80013-2. Cancer Treat Rev. 1980. PMID: 7438127 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters